Microbot Medical Heads Into Holiday Break With MBOT Under Pressure After LIBERTY Concerns
Microbot Medical Inc. stock slipped Friday, closing at $1.71, down 3.93%, with volume at about 1.29 million shares, according to the company’s LSEG-sourced data. The move put pressure on shares heading into the holiday-shortened week, as MBOT lagged while U.S. indexes climbed. The shift is important now as the company ramps from a limited launch to full commercial rollout of its LIBERTY endovascular robotic system. Endovascular procedures use catheters to work within blood vessels.
